HROW has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HROW has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). Harrow's Average Total Inventories for the three months ended in Dec. 2023 was $9.9 Mil. Harrow's Cost of Goods Sold for the three months ended in Dec. 2023 was $11.3 Mil. Hence, Harrow's Days Inventory for the three months ended in Dec. 2023 was 79.89.
The historical rank and industry rank for Harrow's Days Inventory or its related term are showing as below:
During the past 13 years, Harrow's highest Days Inventory was 124.56. The lowest was 45.10. And the median was 69.96.
Harrow's Days Inventory declined from Dec. 2022 (87.51) to Dec. 2023 (79.89).
Inventory Turnover measures how fast the company turns over its inventory within a year. Harrow's Inventory Turnover for the three months ended in Dec. 2023 was 1.14.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Harrow's Inventory-to-Revenue for the three months ended in Dec. 2023 was 0.27.
The historical data trend for Harrow's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harrow Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 55.95 | 91.65 | 81.95 | 77.35 | 80.15 |
Harrow Quarterly Data | ||||||||||||||||||||
Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
Days Inventory | Get a 7-Day Free Trial | 87.51 | 86.24 | 80.52 | 79.22 | 79.89 |
For the Drug Manufacturers - Specialty & Generic subindustry, Harrow's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Harrow's Days Inventory distribution charts can be found below:
* The bar in red indicates where Harrow's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Harrow's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
Days Inventory (A: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Dec. 2022 ) | + | Total Inventories (A: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Dec. 2023 ) | * | Days in Period |
= | ( (6.541 | + | 10.867) | / | 2 ) | / | 39.64 | * | 365 |
= | 8.704 | / | 39.64 | * | 365 | ||||
= | 80.15 |
Harrow's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:
Days Inventory (Q: Dec. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Sep. 2023 ) | + | Total Inventories (Q: Dec. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Dec. 2023 ) | * | Days in Period |
= | ( (8.924 | + | 10.867) | / | 2 ) | / | 11.302 | * | 365 / 4 |
= | 9.8955 | / | 11.302 | * | 365 / 4 | ||||
= | 79.89 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harrow (NAS:HROW) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Harrow's Inventory Turnover for the three months ended in Dec. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 11.302 | / | 9.8955 | |
= | 1.14 |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Harrow's Inventory to Revenue for the three months ended in Dec. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 9.8955 | / | 36.355 | |
= | 0.27 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of Harrow's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Mark L Baum | director, 10 percent owner, officer: Chief Executive Officer | C/O IMPRIMIS PHARMACEUTICALS, INC, 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130 |
Opaleye Management Inc. | 10 percent owner | ONE BOSTON PLACE, SUITE 2600, BOSTON MA 02108 |
Martin A. Makary | director | 102 WOODMONT BLVD., SUITE 610, NASHVILLE TN 37205 |
Van Horn R. Lawrence | director | 354 COOL SPRINGS BLVD., SUITE 106, FRANKLIN TN 37067 |
Andrew Boll | officer: VP, Accounting and Reporting | 437 S HWY 101, STE 209, SOLANA BEACH CA 92075 |
Lindstrom Richard L Md | director | 2811 WESTWOOD PL, WAYZATA MN 55391 |
Perry J. Sternberg | director | 102 WOODMONT BLVD., SUITE 610, NASHVILLE TN 37205 |
Teresa Sparks | director | 40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215 |
Robert J Kammer | director, 10 percent owner, officer: Chairman of the Board | 1440 28TH STREET, SUITE 9, BOULDER CO 80303 |
Longboard Capital Advisors, Llc | other: Institutional Investor | 9665 WILSHIRE BLVD., SUITE 430, BEVERLY HILLS CA 90212 |
Brett Conrad | other: Managing Mbr of Longboard Cap. | 1312 CEDAR ST., SANTA MONICA CA 90405 |
Clayton D Edwards | officer: Chief Operating Officer | 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130 |
Anthony Principi | director | 2300 WEST PLANO PARKWAY, M/S D2420, PLANO TX 75244 |
Donald Paul Miloni | 10 percent owner | 1425 GREENWOOD LANE, GREENWOOD VILLAGE CO 80125 |
John P. Saharek | officer: Chief Commercial Officer | 12264 EL CAMINO REAL, SUITE 350, SAN DIEGO CA 92130 |
From GuruFocus
By Business Wire • 11-20-2023
By Business Wire • 11-29-2023
By Business Wire • 07-26-2023
By Business Wire • 07-18-2023
By PRNewswire PRNewswire • 04-15-2023
By GuruFocus Research • 09-21-2023
By PRNewswire PRNewswire • 03-30-2023
By Business Wire • 10-30-2023
By Business Wire • 10-24-2023
By Business Wire • 09-29-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.